Cannabigerol (CBG)
Also called CBG, hemp CBG, CBG isolate.
Best grade D across 3 graded outcomes Botanical Last checked
The short answer
From 9 sourcesCannabigerol (CBG) is a minor hemp cannabinoid marketed for calm, focus and sleep. Human data are three small trials: 20 mg lowered anxiety and stress versus placebo in 34 healthy adults, single doses up to 200 mg showed no robust effects, and 25–50 mg daily for 4 weeks did not beat placebo for sleep in veterans (grade D).
Every graded outcome on this page
3 rows · line = participantsKey facts
- Anxiety and stress
- A single 20 mg dose lowered anxiety and stress versus placebo in a 34-person crossover trial1
- Dose-ranging
- Single doses of 25 to 200 mg were well tolerated in 12 adults, with no robust effects2
- Sleep
- In 63 veterans with sleep problems, 25 mg then 50 mg daily for 4 weeks improved sleep scores no more than placebo7
- Sport
- CBG is prohibited by WADA, and it was found in urine of people using a broad-spectrum CBD product3
- Typical use
- Surveyed users reported typical doses of 10 to 12 mg, mainly for sleep, pain and anxiety4
What it is
Cannabigerol (CBG) is a non-intoxicating cannabinoid from hemp, sold as an isolate or in broad-spectrum CBD products.
Forms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Cannabigerol (CBG) forms compared
2 forms| 2 forms | CBG isolate (oil or capsules) | Hemp-derived CBG tincture |
|---|---|---|
| Absorption in people | Blood levels rose in proportion to dose from 25 to 200 mg but varied widely between people. With a single 25 mg dose, a high-fat meal raised blood levels more than an emulsified formulation did.28 | No head-to-head human data. |
| GI tolerance | No drug-related adverse events and normal liver tests after single doses up to 200 mg.2 | No subjective drug effects or impairment after 20 mg.1 |
| Studied for | Safety and blood levels | Acute anxiety and stress |
- CBG isolate (oil or capsules)
- Absorption in people
- Blood levels rose in proportion to dose from 25 to 200 mg but varied widely between people. With a single 25 mg dose, a high-fat meal raised blood levels more than an emulsified formulation did.28
- GI tolerance
- No drug-related adverse events and normal liver tests after single doses up to 200 mg.2
- Studied for
- Safety and blood levels
- Hemp-derived CBG tincture
- Absorption in people
- No head-to-head human data.
- GI tolerance
- No subjective drug effects or impairment after 20 mg.1
- Studied for
- Acute anxiety and stress
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
3 graded outcomes, largest study first3 graded outcomes: 1 improved, 2 no effect. The largest, a 2026 randomized trial of 63 people on sleep quality, quality of life and PTSD symptoms, found no effect.
1Sleep quality, quality of life and PTSD symptoms
No effect · Grade D · RCT, 63 people, 2026
US veterans with sleep problems, enrolled remotely
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Sleep quality, quality of life and PTSD symptoms | No effect | 63 | Grade D · RCT, 2026 | US veterans with sleep problems, enrolled remotely |
| Anxiety, stress and mood after a single dose | Improved | 34 | Grade D · Crossover RCT, 2024 | Healthy adults, tested remotely over video (USA) |
| Safety, subjective effects and blood levels | No effect | 12 | Grade D · PK study, 2026 | Healthy adults (USA) |
Every graded row
3 rowsDGrade DSleep quality, quality of life and PTSD symptomsSleepNo effectRCT
n 63 · 2026
No effect Sleep scores improved in both groups with no significant difference between CBG and placebo; quality-of-life and PTSD scores followed the same pattern. CBG was well tolerated.
- Design
- RCT, n = 63, 2026
- Population
- US veterans with sleep problems, enrolled remotely
- Form
- CBG tablets (25 mg)
- Dose
- 25 mg daily for 2 weeks, then 50 mg daily for 2 weeks
- Duration
- 4 weeks after a 2-week run-in
- Source
- Reference 7 · PubMed 41574318 (opens PubMed)
DGrade DAnxiety, stress and mood after a single doseAnxietyImprovedCrossover RCT
n 34 · 2024
Improved Anxiety was lower overall and stress lower at the first time point than with placebo, and verbal memory was better. There were no subjective drug effects or impairment.
- Design
- Crossover RCT, n = 34, 2024
- Population
- Healthy adults, tested remotely over video (USA)
- Form
- Hemp-derived CBG tincture
- Dose
- 20 mg single dose vs placebo
- Duration
- Two sessions one week apart
- Source
- Reference 1 · PubMed 39003387 (opens PubMed)
DGrade DSafety, subjective effects and blood levelsSafetyNo effectPK study
n 12 · 2026
No effect No drug-related adverse events and no liver test above normal. Subjective effects were minimal and inconsistent (less jittery at 50 mg, less calm at 100 mg, more appetite at 200 mg); blood levels rose with dose but varied widely between people.
- Design
- PK study, n = 12, 2026
- Population
- Healthy adults (USA)
- Form
- CBG isolate in MCT oil
- Dose
- Single ascending doses of 25, 50, 100 and 200 mg, plus placebo
- Duration
- Single doses, 8 hours of sampling each
- Source
- Reference 2 · PubMed 42575778 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
When trials measured an effect
1 outcome| Outcome | Measured at | Basis |
|---|---|---|
| Anxiety and stress in healthy adults | Within the same session, shortly after a single 20 mg dose | Stress was lower than with placebo at the first rating after dosing; anxiety was lower across the session1 |
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
What Cannabigerol meets
1 cited rowMedicines 1
Supplements and foods 0
No supplement rows in our sources.
- Measured in a human study
Choose a medicine or supplement above to read its cited rows here.
Also cited:
Medicines cleared by liver CYP enzymes
PK studyMeasured in a human study
Medicines cleared by liver CYP enzymes, for example drugs metabolized by CYP3A4, CYP2D6, CYP2C8 or CYP2C9: In lab and mouse studies, CBG was rapidly broken down by the human liver enzymes CYP3A4, CYP2D6, CYP2C8, CYP2C9 and CYP2J2, which also clear many medicines. No human interaction study appears in our sources, so the size of any effect is unknown.
Source 5, Biochemistry (2022)
Interactions
1 agent| Agent | What the source says | Evidence |
|---|---|---|
| Medicines1 | ||
| Medicines cleared by liver CYP enzymese.g. drugs metabolized by CYP3A4, CYP2D6, CYP2C8 or CYP2C9 | In lab and mouse studies, CBG was rapidly broken down by the human liver enzymes CYP3A4, CYP2D6, CYP2C8, CYP2C9 and CYP2J2, which also clear many medicines. No human interaction study appears in our sources, so the size of any effect is unknown.5 | PK study |
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Cannabigerol and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Cannabigerol.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
4 groups- Athletes in tested sports
- WADA prohibits cannabinoids other than CBD, including CBG, and CBG appeared in the urine of 42 to 74% of people using a broad-spectrum CBD product.3
- Legal status (United States)
- Hemp-derived CBG is sold under the 2018 farm bill's hemp definition. A November 2025 federal law narrows that definition from November 12, 2026, excluding final products with more than 0.4 mg of total THC per container and cannabinoids made outside the plant; state laws also differ.6
Reading the label, and the cost per dose
Compare any product you already have by the amount it delivers, not by capsule count or front-of-pack weight.
How to read the label
2 checksHave the bottle? Photograph its Supplement Facts panel and see each line, cannabigerol (cbg) included, beside the doses and forms the trials used in Label X-Ray.
Cost per studied dose, without the sales pitch
Your numbers, no product dataEnter the price, servings and the amount per serving from your label.
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersDoes CBG help anxiety?
In one crossover trial, a single 20 mg dose lowered anxiety and stress versus placebo in 34 healthy adults. No trial has tested repeated use or people with anxiety disorders.1
Does CBG help you sleep?
Not on current evidence. In a 4-week trial in 63 veterans with sleep problems, 25 mg then 50 mg daily improved sleep scores no more than placebo. The trial was smaller than planned, and its lead author works for the sponsor company.7
Does CBG get you high?
Is CBG safe?
What is the difference between CBG and CBD?
Can CBG fail a drug test?
CBG is on WADA's prohibited list, and it was detected in urine of people using a broad-spectrum CBD product, more so after exercise. THC was not detected in that study.3
Sources
9 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
9 sources- 1Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial.Crossover RCT Sci Rep, 2024 · PMID 39003387
- 2Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults.PK study J Pharmacol Exp Ther, 2026 · PMID 42575778
- 3Daily Use of a Broad-Spectrum Cannabidiol Supplement Produces Detectable Concentrations of Cannabinoids in Urine Prohibited by the World Anti-Doping Agency: An Effect Amplified by Exercise.RCT Med Sci Sports Exerc, 2026 · PMID 40920736
- 4A Survey of Cannabigerol User's Patterns of Use, Perceived Efficacy and Satisfaction.Observational J Psychoactive Drugs, 2026 · PMID 42741890
- 5Metabolites of Cannabigerol Generated by Human Cytochrome P450s Are Bioactive.Animal study Biochemistry, 2022 · PMID 36223199
- 6Change to Federal Definition of Hemp and Implications for Federal Enforcement (CRS Insight IN12620)Fact sheet Congressional Research Service, 2025 · congress.gov
- 7Effect of Cannabigerol on Sleep and Quality of Life in Veterans: A Decentralized, Randomized, Placebo-Controlled Trial.RCT Med Cannabis Cannabinoids, 2026 · PMID 41574318
- 8Impact of Dietary Fat and Oral Delivery System on Cannabigerol Pharmacokinetics in Adults.PK study Cannabis Cannabinoid Res, 2024 · PMID 38574248
- 9What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding (content current as of October 16, 2019)Safety communication U.S. Food and Drug Administration, 2019 · fda.gov
What changed
Every dated change to this page: what changed, who made it and why.
Change log
4 entries| Date | Change | Who and why |
|---|---|---|
| summary, key facts, evidence, studied doses, forms, who should avoid, time to effect, FAQ, questions, related | Added a 2026 randomized trial of CBG for sleep in 63 veterans (no difference from placebo, grade D; n from full text) and a 2024 study showing a high-fat meal raises CBG absorption. Pregnancy note now cites the FDA consumer update on cannabis in pregnancy and breastfeeding (LactMed and LiverTox have no CBG entry). Interactions re-checked: still no human interaction study (LiverTox, LactMed and PubMed searched). Added a sleep FAQ, time to effect, page questions and related links. Not added: a 2023 recovery trial of a CBD, CBG and amino acid blend (37947792; effects cannot be attributed to CBG) and an unblinded 2026 pain study of mixed cannabinoid capsules (42140793). | Writer: Kymata Health EditorialTrigger: A–Z audit against docs/supplements/AUDIT-STANDARD.md |
| safety | Independent review: added a US legal-status note (CRS summary of P.L. 119-37) and a possible drug-interaction note based on CBG's metabolism by human CYP enzymes (PubMed-verified). | Writer: Kymata Health EditorialTrigger: review |
| all | First draft. Every PMID checked against NCBI E-utilities esummary (title and year taken from the record) and abstracts read for every cited row. | Writer: Kymata Health EditorialTrigger: new page |
| all | Adversarial review pass: every evidence row's numbers machine-checked against its PubMed abstract, retraction and erratum flags checked for all PMIDs, unverified country and affiliation details removed, and claims not supported by the cited abstracts reworded or dropped. | Writer: Kymata Health EditorialTrigger: review |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.